El manejo del asma como enfermedad inflamatoria crónica y problema sanitario global: documento de posicionamiento de las sociedades científicas

2017, Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet Respir Med., 5, 691, 10.1016/S2213-2600(17)30293-X Global Asthma Network. The Global Asthma Report 2018 2018 [consultado 28 Feb 2020]. Disponible en: http://www.globalasthmareport.org/Global%20Asthma%20Report%202018.pdf. GEMA 4.4-Guía española para el manejo del asma. Madrid: Comité Ejecutivo de la GEMA; 2019 [consultado 28 Feb 2020]. Disponible en: https://www.gemasma.com/ Aaron, 2018, Underdiagnosis and Overdiagnosis of Asthma, Am J Respir Crit Care Med., 198, 1012, 10.1164/rccm.201804-0682CI Gómez Sáenz, 2019, Mortalidad por asma en España 1990-2015, Medicina de familia SEMERGEN., 45, 449, 10.1016/j.semerg.2019.02.014 Instituto Nacional de Estadística. INEbase-Defunciones según la Causa de Muerte 2019 [consultado 28 Feb 2019]. Disponible en: https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176780&menu=ultiDatos&idp=1254735573175 Price, 2014, Asthma control and management in 8,000 European patients: The REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey, NPJ Prim Care Respir Med., 24, 14009, 10.1038/npjpcrm.2014.9 Accordini, 2013, The cost of persistent asthma in Europe: an international population-based study in adults, Int Arch Allergy Immunol., 160, 93, 10.1159/000338998 Dominguez-Ortega, 2015, Cost-effectiveness of asthma therapy: A comprehensive review, J Asthma., 52, 529, 10.3109/02770903.2014.999283 2019 GINA Report, Global Strategy for Asthma Management and Prevention 2019 [consultado Jun 2019]. Disponible en: https://ginasthma.org/gina-reports/ Halm, 2006, No symptoms, no asthma: The acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma, Chest., 129, 573, 10.1378/chest.129.3.573 Serrano-Pariente, 2017, Near-fatal asthma: A heterogeneous clinical entity, Curr Opin Allergy Clin Immunol., 17, 28, 10.1097/ACI.0000000000000333 Bloom, 2019, Exacerbation patterns in adults with asthma in England. A population-based study, Am J Respir Crit Care Med., 199, 446, 10.1164/rccm.201808-1516OC Reddel, 2017, Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: A post-hoc efficacy analysis of the START study, Lancet., 389, 157, 10.1016/S0140-6736(16)31399-X Levy, 2015, The national review of asthma deaths: What did we learn and what needs to change?, Breathe (Sheff)., 11, 14, 10.1183/20734735.008914 Asthma UK calls for action to end preventable asthma deaths: Asthma UK; 2017 [consultado 28 Feb 2020]. Disponible en: https://www.asthma.org.uk/about/media/news/asthma-deaths-2017/ Bush A, Pavord ID. The lancet asthma commission: Towards the abolition of asthma? Eur Med Journal [Internet]. 2018 [consultado Feb 2019]. Disponible en: https://www.emjreviews.com/respiratory/article/the-lancet-asthma-commission-towards-the-abolition-of-asthma/ Pavord, 2018, After asthma: Redefining airways diseases, Lancet., 391, 350, 10.1016/S0140-6736(17)30879-6 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J., 26, 948, 10.1183/09031936.05.00035205 Kitch, 2004, A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up, Chest., 126, 1875, 10.1378/chest.126.6.1875 Blanco Aparicio, 2019, Referral criteria for asthma: Consensus document, J Investig Allergol Clin Immunol., 29, 422, 10.18176/jiaci.0393 Valero, 2019, Re-evolution of asthma management: Dilemmas and new paradigms, J Investig Allergol Clin Immunol., 29, 15, 10.18176/jiaci.0345 Hyland, 2004, Asthma treatment needs: A comparison of patients’ and health care professionals’ perceptions, Clin Ther., 26, 2141, 10.1016/j.clinthera.2004.12.017 Prieto, 2007, Asthma control: Do patients’ and physicians’ opinions fit in with patients’ asthma control status?, J Asthma., 44, 461, 10.1080/02770900701421989 Deschildre, 2014, Asthma control assessment in a pediatric population: Comparison between GINA/NAEPP guidelines Childhood Asthma Control Test (C-ACT), and physician's rating, Allergy., 69, 784, 10.1111/all.12402 O’Byrne, 2017, The paradoxes of asthma management: Time for a new approach?, Eur Respir J., 50 Sastre, 2016, Insights, attitudes, and perceptions about asthma and its treatment: A multinational survey of patients from Europe and Canada, World Allergy Organ J., 9, 13, 10.1186/s40413-016-0105-4 Levy ML, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills. National Review of Asthma Deaths (NRAD) 2015 [consultado 28 Feb 2020]. Disponible en: https://www.rcplondon.ac.uk/projects/national-review-asthma-deaths Du, 2017, Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis, Exp Ther Med., 14, 1594, 10.3892/etm.2017.4694 O’Byrne, 2009, Severe exacerbations and decline in lung function in asthma, Am J Respir Crit Care Med., 179, 19, 10.1164/rccm.200807-1126OC Álvarez-Gutiérrez, 2017, Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care, BMC Pulm Med., 17, 77, 10.1186/s12890-017-0422-6 Lung health in Europe. Facts and figures —A better understanding of lung disease and respiratory care in Europe. Sheffield (RU): European Lung Foundation (ELF); 2013 [consultado 28 Feb 2020]. Disponible en: https://www.europeanlung.org/assets/files/en/publications/lung_health_in_europe_facts_and_figures_web_vfour.pdf Katsaounou, 2018, Still fighting for breath: A patient survey of the challenges and impact of severe asthma, ERJ Open Res., 4 Doz, 2013, The association between asthma control, health care costs, and quality of life in France and Spain, BMC Pulm Med., 13, 15, 10.1186/1471-2466-13-15 Puig-Junoy, 2017, Costes socioeconómicos del asma en la Unión Europea, Estados Unidos y Canadá: revisión sistemática, Rev Esp Salud Publica., 91, e1 Sullivan, 2017, Measuring the cost of poor asthma control and exacerbations, J Asthma., 54, 24, 10.1080/02770903.2016.1194430 Camargo, 2018, Transformational thinking about asthma, Lancet., 391, e2, 10.1016/S0140-6736(17)32126-8 Bateman, 2010, Overall asthma control: The relationship between current control and future risk, J Allergy Clin Immunol., 125, 600, 10.1016/j.jaci.2009.11.033 Patel, 2015, The use of beta2-agonist therapy before hospital attendance for severe asthma exacerbations: A post-hoc analysis, NPJ Prim Care Respir Med., 25, 14099, 10.1038/npjpcrm.2014.99 Selroos, 1995, Effect of early vs. late intervention with inhaled corticosteroids in asthma, Chest., 108, 1228, 10.1378/chest.108.5.1228 Pilcher, 2017, Beta-agonist overuse and delay in obtaining medical review in high risk asthma: A secondary analysis of data from a randomised controlled trial, NPJ Prim Care Respir Med., 27, 33, 10.1038/s41533-017-0032-z Ebmeier, 2017, Trends in international asthma mortality: Analysis of data from the WHO Mortality Database from 46 countries (1993-2012), Lancet., 390, 935, 10.1016/S0140-6736(17)31448-4 Busse, 2008, The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: Effectiveness of early intervention with budesonide in mild persistent asthma, J Allergy Clin Immunol., 121, 1167, 10.1016/j.jaci.2008.02.029 Selroos, 2008, Effect of disease duration on dose-response of inhaled budesonide in asthma, Respir Med., 102, 1065, 10.1016/j.rmed.2007.12.029 Nannini, 2018, Treatment step 1 for asthma should not be left blank, and SABA-only might not be a treatment step 1 option for asthma, Respiration., 95, 212, 10.1159/000484568 Pauwels, 2003, Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial, Lancet., 361, 1071, 10.1016/S0140-6736(03)12891-7 Buhl, 2012, The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy, Respir Res., 13, 59, 10.1186/1465-9921-13-59 Suissa, 2001, Inhaled corticosteroids: Impact on asthma morbidity and mortality, J Allergy Clin Immunol., 107, 937, 10.1067/mai.2001.115653 Suissa, 2000, Low-dose inhaled corticosteroids and the prevention of death from asthma, N Engl J Med., 343, 332, 10.1056/NEJM200008033430504 Suissa, 2002, Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma, Thorax., 57, 880, 10.1136/thorax.57.10.880 Agertoft, 1994, Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children, Respir Med., 88, 373, 10.1016/0954-6111(94)90044-2 Waljee, 2017, Short term use of oral corticosteroids and related harms among adults in the United States: Population based cohort study, BMJ., 357 Bloechliger, 2018, Adverse events profile of oral corticosteroids among asthma patients in the UK: Cohort study with a nested case-control analysis, Respir Res., 19, 75, 10.1186/s12931-018-0742-y Volmer, 2018, Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: A focused review of the impact data in the literature, Eur Resp J., 52, 1800703, 10.1183/13993003.00703-2018 Organización Mundial de la Salud. Chronic diseases and health promotion. Adherence to long-term therapies: Evidence for action 2003 [consultado 28 Feb 2020]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf;jsessionid=67A50A7C0DEE325C6C4056D1483CBD3A?sequence=1 Partridge, 2006, Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study, BMC Pulm Med., 6, 13, 10.1186/1471-2466-6-13 Federación Empresarial de Farmacéuticos Españoles (FEFE). Observatorio del medicamento- Ene 2019-2019 [consultado 28 Feb 2020]. Disponible en: https://www.actasanitaria.com/wp-content/uploads/2019/03/Observatorio-del-Medicamento_enero19LP.pdf Gibson, 2004, Written action plans for asthma: An evidence-based review of the key components, Thorax., 59, 94, 10.1136/thorax.2003.011858 Menckeberg, 2008, Beliefs about medicines predict refill adherence to inhaled corticosteroids, J Psychosom Res., 64, 47, 10.1016/j.jpsychores.2007.07.016 Mishra, 2017, Role of adult asthma education in improving asthma control and reducing emergency room utilization and hospital admissions in an inner city hospital, Can Respir J., 2017, 5681962, 10.1155/2017/5681962 Mayo, 1990, Results of a program to reduce admissions for adult asthma, Ann Intern Med., 112, 864, 10.7326/0003-4819-112-11-864